Concord Biotech informs about investor presentation

09 Feb 2024 Evaluate
Pursuant to Regulation 30 of Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has informed that investor’s presentation on Financial Results for the Third quarter and Nine months ended December 31, 2023 is enclosed.

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

1507.55 3.35 (0.22%)
14-May-2024 10:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.60
Dr. Reddys Lab 5884.55
Cipla 1382.95
Zydus Lifesciences 998.65
Lupin 1644.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.